Editorial Policies

Focus and Scope

Folia Medica Indonesiana publishes articles in whole aspects of medical sciences, including pre-clinical medicines such as biomedicine, anatomy, histology, biochemistry, physiology, microbiology, parasitology, pathology, and pharmacology; clinical medicines, such as obstetrics and gynecology, pediatrics, internal medicine, ophthalmology, surgery, neurology, otholaryngology, cardiology, anaesthesiology; as well as rehabilitative medicine, public health, and preventive medicine. The articles are presented as original article, case reports and literature review.

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Reports

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Publication Frequency

Folia Medica Indonesiana is published four times a year in March, June, September and December. Each issue publishes thirteen articles or fifty-two articles in each calender year.

 

Open Access Policy

Folia Medica Indonesiana provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, or to use them for any other lawful purpose.

 

Reference Manager

Every article submitted to FMI shall use reference management software e.g. EndNote® or Mendeley.

 

Publication Ethics and Malpractice Statement

Folia Medica Indonesiana (hence FMI) is a journal aims to publish original research papers, review articles, and case studies focused on original basic medical and clinical articles presented as original articles, review articles, and case report. This following statement clarifies ethical behavior of all parties involved in the act of publishing an article in this journal, including the author, the editor and the reviewer.

 

  1. A. Duties of Authors
  1. Submission:

Authors must submit all elements of their manuscripts online at http://e-journal.unair.ac.id/index.php/FMI/about/submissions#onlineSubmissions. Hard-copy submissions will NOT be considered or returned. A completed Disclaimer, which can be downloaded from this website, signed by all authors must accompany all submissions.

  1. Human and Animal Subjects: 

The research being reported should have been conducted in an ethical and responsible manner and should comply with all relevant legislation. For manuscripts reporting medical studies involving human participants, authors must provide a statement identifying the ethics committee that approved the study, and the study conforms to recognized standards (for example Declaration of Helsinki). Research involving animals should be conducted with the same rigor as research in humans. Authors should implement the 3Rs principles (Replacement, Reduction, Refinement). Authors must describe the details journals regarding study design and statistical analysis, experimental procedures, experimental animals, housing and husbandry. Authors must inform that ethical and legal approval was obtained prior to the start of the study, and to state the name of the body giving the approval. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines and regulations.

  1. Reporting Manuscript’s Standards: 

Authors must present an accurate account of the original article (research, review, or case report) performed as well as an objective discussion of its significance. Authors should present their results clearly, honestly, and without fabrication, falsification or inappropriate data manipulation. Authors should strive to describe their methods clearly and unambiguously so that their findings can be confirmed by others. Fraudulent or knowingly inaccurate statements constitute unethical behavior and will be unacceptable.

  1. Originality and Plagiarism: 

Authors must ensure that they have written manuscripts that adhere to publication requirements that submitted work is original, is not plagiarized, and has not been published elsewhere. The manuscript should not be submitted concurrently to more than one publication unless the editors have agreed to co-publication. Relevant previous work and publications, both by other researchers and the authors’ own, should be properly acknowledged and referenced. The primary literature should be cited where possible. Original wording taken directly from publications by other researchers should appear in quotation marks with the appropriate citations.

  1. Duplicate and Redundant Publications: 

Authors must avoid duplicate publication, which is reproducing verbatim content from their other publications. Authors should not submit and also expected will not publish redundant manuscripts or manuscripts describing same research in more than one journal. Multiple publications arising from a single research project should be clearly identified as such and the primary publication should be referenced

  1. Acknowledgement of Sources: 

All sources of data used in the research and cite publications that have been influential in determining the nature of the reported work should be properly identified. Authors must present a proper acknowledgment of the work of others.

  1. Authorship of the Paper: 

The authorship of research publications should accurately reflect individuals’ contributions to the work and its reporting. Authors ensure that all the authors have seen and agreed to the submitted version of the manuscript and their inclusion of names as co-authors. Authorship should be limited to those who have made a significant contribution to conception, design, execution or interpretation of the reported study. Others who have made significant contribution must be listed as co-authors. In cases where major contributors are listed as authors while those who made less substantial, or purely technical, contributions to the research or to the publication are listed in an acknowledgement section.

  1. Disclosure and Conflicts of Interest: 

Funding sources and relevant conflicts of interest should be disclosed. Authors have to clearly disclose any financial or other substantive conflict of interest that might be supposed to influence the results or interpretation of their manuscripts.

  1. Fundamental Errors in Published Works: 

In case the author discovers an error or inaccuracy in their submitted manuscript, the author should promptly notify the journal editor or publisher and cooperate with the editor to or correct the paper.

 

Duties of Editor

  1. Publication Decisions: 

Editors are accountable and should take responsibility for everything they publish. Editors should apply consistent standards in their processes so that have procedures and policies in place to ensure the quality of the material they publish and maintain the integrity of the published record. Based on the review report of the editorial board, the editor can accept, reject, or request modifications to the manuscript. Editors should aim to ensure timely peer review and publication and should avoid unnecessary delays. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism that encourage maximum transparency and complete, honest reporting.

  1. Review of Manuscripts: 

Editor must ensure that each manuscript is initially evaluated by the editor for originality. Editors should critically assess the ethical conduct of studies in humans and animals. The editor should organize and use peer review fairly and wisely. Editors should explain their peer review processes in the information for authors and also indicate which parts of the journal are peer reviewed. Editor should use appropriate peer reviewers for papers that are considered for publication by selecting people with sufficient expertise and avoiding those with conflicts of interest.

  1. Fair Play: 

Editors should make fair and unbiased decisions independent from commercial consideration and ensure a fair and appropriate peer review process. The editor must ensure that each manuscript received by the journal is reviewed for its intellectual content without regard to sex, gender, race, religion, citizenship, etc. of the authors. Editors are in a powerful position by making decisions on publications, which makes it very important that this process is as fair and unbiased as possible.

  1. Confidentiality: 

Editors should ensure confidential handling of manuscripts, with no details being disclosed to anyone except the peer reviewers without the permission of the author. If discussions between an author, editor, and peer reviewer have taken place in confidence, they should remain in confidence unless explicit consent has been given by all parties, or unless there are exceptional circumstances (eg, when they might help substantiate claims of intellectual property theft during peer review).

  1. Disclosure and Conflicts of Interest: 

Editors should guard the integrity of the published record by issuing corrections and retractions when needed and pursuing suspected or alleged research and publication misconduct. The editor of the Journal will not use unpublished materials disclosed in a submitted manuscript for his own research without written consent of the author. And also, editors should not be involved in decisions about papers in which they have a conflict of interest.

 

Duties of Reviewers

Manuscripts submitted for publication in Folia Medica Indonesiana journals are subjected to double blind peer-review. Double blind reviewing maintains the identity of the authors as well as the reviewers, not disclosing their names to each other. The anonymity of authors and reviewers ensures objective and unbiased assessment of the manuscript.

  1. Confidentiality: 

Information regarding manuscripts submitted by authors should be kept confidential and be treated as privileged information. They must not be shown to or discussed with others except as authorized by the editor.

  1. Standards of Objectivity: 

Review of submitted manuscripts must be done objectively and the reviewers should express their views clearly with supporting arguments. The results reported in the manuscript must be original and authentic work of the authors. They should be devoid of any plagiarism and the material should not have been published earlier. Experiments and other analyses should meet the recognized technical standards and must be described systematically. Manuscript must provide a statement identifying the ethics committee that approved the study, and the study conforms to recognized standards. The research presented in a manuscript should facilitate in reaching accurate conclusions from the statistics. Methods and experiments as well as reagents should be documented in detail. Authors should present and interpret the results and conclusions in an appropriate and comprehensive manner, clearly explaining the results and outcomes of their study. Incomplete interpretation of results may result in rejection of the manuscript. Furthermore, the manuscript should be written in English in a clear, direct and active style, free from grammatical errors and other linguistic inconsistencies. All pages should be numbered sequentially, facilitating the reviewing and editing of the manuscript (see duties of Authors).

  1. Disclosure and Conflict of Interest: 

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.  Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

  1. Promptness: 

The reviewers should respond in a reasonable time-frame. If they cannot return a review within the proposed time, they should inform the journal promptly and explain they require an extension. In the event that a reviewer feels it is not possible for him/her to complete review of manuscript within stipulated time then this information must be communicated to the editor, so that the manuscript could be sent to another reviewer.

 

Note:

Fabrication:

Fabrication is the making up (manufacturing) of all or parts of an experiment or clinical data as reported in a submitted or published manuscript in the Folia Medica Indonesiana.

 

Falsification:

Falsification is the false reporting of data, methods, or circumstances in the experiment or study as reported in the submitted manuscript or published article in the Folia Medica Indonesiana.

 

Plagiarism

Plagiarism is the appropriation of ideas, thoughts, or language of another person and their representation as one’s own original work in a submitted manuscript or article published in the Folia Medica Indonesiana. The ideas, thoughts, or language that was appropriated may never have been published or was in manuscript form, was printed by an institute for local consumption, or was published in a journal, book, or other medium for public consumption. In the submitted manuscript or published article in the Folia Medica Indonesiana there is no notation or mention of the person whose ideas, thoughts, or language was appropriated, and the author fails to provide any information to the Editors regarding these circumstances.

 

Peer Review Process

Any manuscript submitted to this journal is first checked by an editor for evaluating whether the manuscript is suitable with the journal's aim and scope, the completions of all elements of manuscript, such as the IMRAD, the clearness of tables and figures, proper referencing, and also possible plagiarism. The author will be notified if flaws are found in this step within three days after submission. Once there are no flaws, the author is eligible to receive Letter of Submission, and the manuscript is further submitted to reviewers. They are appointed from other institutions, either national or international. The reviewing process is double-blind peer reviewed, in which the author not knowing who reviews his/her manuscript, while, as the manuscript itself sent anonimously, the reviewers not knowing who the authors are. Reviewers' comments are sent anonimously to the author for revision. The revised manuscript will be discussed in regular meeting of the editorial board where the final decision regarding the publication eligibility of the manuscript is decided. Once a revised manuscript is regarded as eligible for publication, a Letter of Acceptance is issued for the corresponding author. The whole process is generally completed within 6-10 weeks.

 

Article Processing Charge

Article processing charge for publication in Folia Medica Indonesiana is IDR 1.5 Million. Payment is due after the manuscript is accepted for publication in the journal. The journal does not require any submission charge.

Waiver Policy

We will consider all requests for discretionary APC waivers by researchers who are not eligible for the above. Please state your request for discretionary waiver prior to submitting your manuscript by email to the APC team at fmi@journal.unair.ac.id.

A range of discounts or waivers are offered to authors who are unable to pay our article publishing charges. These are dependent on current availability of funds for free waivers. We use the World Bank Country Classification table and some criteria to identify:

  1. Low income countries. Contact authors whose primary affiliation is in these countries will be eligible for up to a 100% waiver of the standard article publishing charge;
  2. Lower middle income. Contact authors whose primary affiliation is in these countries will be eligible for a 50% waiver of the standard article publishing charge;
  3. Students without grant scholarship;
  4. Young staff and equal (below 38 years old) with difficulty of payment; and
  5. In-bound students.
Please include supporting evidence for why a waiver would be necessary in your circumstances. Your request should be details of:
  1. The affiliation and country of residence of all authors;
  2. Details of where the research was conducted; and
  3. Confirmation of all research grant funding received.
If you have already accepted a discounted price offered to you at the time of submission, please be aware that this is the maximum discount and we are unable to help you further.
 
Authors who receive the support of, or are employed by, a commercial organization (e.g., Pharmaceutical company) will not be liable to receive this discounted price. They will be asked to pay the full advertised price in effect at the time of submission.
 
Discounts may not be combined and where multiple discounts are available the one most favorable to the authors will apply.
 
Discounts can be determined by journal managers only if the authors have already submitted their waiver request through fmi@journal.unair.ac.id.

Waiver request form can be downloaded here.

 

Plagiarism Check

The editors of Folia Medica Indonesiana will screen all submitted manuscripts for plagiarism using Turnitin plagiarism checker. Similarity of more than 20% is not acceptable.

 

External Links

Folia Medica Indonesiana (FMI) is now under cooperation with Unit Konsorsium Jurnal dan FMI (UKJF), Faculty of Medicine, Universitas Airlangga. The information can be accessed through an external link https://ukjf.fk.unair.ac.id/.

 

Repository Policy

FMI allows authors to deposit versions of their work. All of published articles in FMI are deposited in Portal Garuda repository.